|
1
|
Nataraj V, Batra A, Rastogi S, Khan SA,
Sharma MC, Vishnubhatla S and Bakhshi S: Developing a prognostic
model for patients with localized osteosarcoma treated with uniform
chemotherapy protocol without high dose methotrexate: A
single-center experience of 237 patients. J Surg Oncol.
112:662–668. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ambroszkiewicz J, Gajewska J, Klepacka T,
Chelchowska M, Laskowska-Klita T and Woźniak W: Clinical utility of
biochemical bone turnover markers in children and adolescents with
osteosarcoma. Adv Med Sci. 55:266–272. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Luisi FA, Petrilli AS, Tanaka C and Caran
EM: Contribution to the treatment of nausea and emesis induced by
chemotherapy in children and adolescents with osteosarcoma. Sao
Paulo Med J. 124:61–65. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ferguson WS, Harris MB, Goorin AM,
Gebhardt MC, Link MP, Shochat SJ, Siegal GP, Devidas M and Grier
HE: Presurgical window of carboplatin and surgery and multidrug
chemotherapy for the treatment of newly diagnosed metastatic or
unresectable osteosarcoma: Pediatric oncology group trial. J
Pediatr Hematol Oncol. 23:340–348. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lu XF, Yang WL, Wan ZH, Li J and Bi ZG:
Glutathione S-transferase polymorphisms and bone tumor risk in
China. Asian Pac J Cancer Prev. 12:3357–3360. 2011.PubMed/NCBI
|
|
6
|
Basu M, Mukhopadhyay S, Chatterjee U and
Roy SS: FGF16 promotes invasive behavior of SKOV-3 ovarian cancer
cells through activation of mitogen-activated protein kinase (MAPK)
signaling pathway. J Biol Chem. 289:1415–1428. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang K, Fu XT, Li Y, Hou YJ, Yang MF, Sun
JY, Yi SY, Fan CD, Fu XY, Zhai J and Sun BL: Induction of S-phase
arrest in human glioma cells by selenocysteine, a natural
selenium-containing agent via triggering reactive oxygen
species-mediated DNA damage and modulating MAPKs and Akt pathways.
Neurochem Res. 41:1439–1447. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hu KH, Li WX, Sun MY, Zhang SB, Fan CX, Wu
Q, Zhu W and Xu X: Cadmium induced apoptosis in MG63 cells by
increasing ROS, activation of p38 MAPK and inhibition of ERK 1/2
pathways. Cell Physiol Biochem. 36:642–654. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen CY, Yi L, Jin X, Zhang T, Fu YJ, Zhu
JD, Mi MT, Zhang QY, Ling WH and Yu B: Inhibitory effect of
delphinidin on monocyte-endothelial cell adhesion induced by
oxidized low-density lipoprotein via ROS/p38MAPK/NF-κB pathway.
Cell Biochem Biophys. 61:337–348. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yu M, Zheng Y, Sun HX and Yu DJ:
Inhibitory effects of enalaprilat on rat cardiac fibroblast
proliferation via ROS/P38MAPK/TGF-beta1 signaling pathway.
Molecules. 17:2738–2751. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gao D, Nong S, Huang X, Lu Y, Zhao H, Lin
Y, Man Y, Wang S, Yang J and Li J: The effects of palmitate on
hepatic insulin resistance are mediated by NADPH Oxidase 3-derived
reactive oxygen species through JNK and p38MAPK pathways. J Biol
Chem. 285:29965–29973. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang ZS, Luo P, Dai SH, Liu ZB, Zheng XR
and Chen T: Salvianolic acid B induces apoptosis in human glioma
U87 cells through p38-mediated ROS generation. Cell Mol Neurobiol.
33:921–928. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guo HD, Cui GH, Tian JX, Lu PP, Zhu QC, Lv
R and Shao SJ: Transplantation of salvianolic acid B pretreated
mesenchymal stem cells improves cardiac function in rats with
myocardial infarction through angiogenesis and paracrine
mechanisms. Int J Cardiol. 177:538–542. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wei J, Xie G, Ge S, Qiu Y, Liu W, Lu A,
Chen T, Li H, Zhou Z and Jia W: Metabolic transformation of
DMBA-induced carcinogenesis and inhibitory effect of salvianolic
acid b and breviscapine treatment. J Proteome Res. 11:1302–1316.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cao W, Guo XW, Zheng HZ, Li DP, Jia GB and
Wang J: Current progress of research on pharmacologic actions of
salvianolic acid B. Chin J Integr Med. 18:316–320. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zeng G, Tang T, Wu HJ, You WH, Luo JK, Lin
Y, Liang QH, Li XQ, Huang X and Yang QD: Salvianolic acid B
protects SH-SY5Y neuroblastoma cells from
1-methyl-4-phenylpyridinium-induced apoptosis. Biol Pharm Bull.
33:1337–1342. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ma L, Guan YQ and Du ZD: Salvianolic acid
B down-regulates matrix metalloproteinase-9 activity and expression
in tumor necrosis factor-α-induced human coronary artery
endothelial cells. Chin Med J (Engl). 128:2658–2663. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Loeb DM, Hobbs RF, Okoli A, Chen AR, Cho
S, Srinivasan S, Sgouros G, Shokek O, Wharam MD Jr, Scott T and
Schwartz CL: Tandem dosing of samarium-153 ethylenediamine
tetramethylene phosphoric acid with stem cell support for patients
with high-risk osteosarcoma. Cancer. 116:5470–5478. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mir O, Ropert S, Babinet A, Alexandre J,
Larousserie F, Durand JP, Enkaoua E, Anract P and Goldwasser F:
Hyper-alkalinization without hyper-hydration for the prevention of
high-dose methotrexate acute nephrotoxicity in patients with
osteosarcoma. Cancer Chemother Pharmacol. 66:1059–1063. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang Y, Ge PJ, Jiang L, Li FL and Zhu QY:
Modulation of growth and angiogenic potential of oral squamous
carcinoma cells in vitro using salvianolic acid B. BMC Complement
Altern Med. 11:542011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mason WP, Belanger K, Nicholas G,
Vallières I, Mathieu D, Kavan P, Desjardins A, Omuro A and Reymond
D: A phase II study of the Ras-MAPK signaling pathway inhibitor
TLN-4601 in patients with glioblastoma at first progression. J
Neurooncol. 107:343–349. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang L, Shu T, Liang Y, Gu W, Wang C, Song
X, Fan C and Wang W: GDC-0152 attenuates the malignant progression
of osteosarcoma promoted by ANGPTL2 via PI3K/AKT but not p38MAPK
signaling pathway. Int J Oncol. 46:1651–1658. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Williamson AJ, Dibling BC, Boyne JR, Selby
P and Burchill SA: Basic fibroblast growth factor-induced cell
death is effected through sustained activation of p38MAPK and
up-regulation of the death receptor p75NTR. J Biol Chem.
279:47912–47928. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Berger S, Dyugovskaya L, Polyakov A and
Lavie L: Short-term fibronectin treatment induces endothelial-like
and angiogenic properties in monocyte-derived immature dendritic
cells: Involvement of intracellular VEGF and MAPK regulation. Eur J
Cell Biol. 91:640–653. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen YY, Hsieh CY, Jayakumar T, Lin KH,
Chou DS, Lu WJ, Hsu MJ and Sheu JR: Andrographolide induces
vascular smooth muscle cell apoptosis through a
SHP-1-PP2A-p38MAPK-p53 cascade. Sci Rep. 4:56512014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hung HH, Chen YL, Lin SJ, Yang SP, Shih
CC, Shiao MS and Chang CH: A salvianolic acid B-rich fraction of
Salvia miltiorrhiza induces neointimal cell apoptosis in rabbit
angioplasty model. Histol Histopathol. 16:175–183. 2001.PubMed/NCBI
|
|
27
|
Lan A, Xu W, Zhang H, Hua X, Zheng D, Guo
R, Shen N, Hu F, Feng J and Liu D: Inhibition of ROS-activated
p38MAPK pathway is involved in the protective effect of H2S against
chemical hypoxia-induced inflammation in PC12 cells. Neurochem Res.
38:1454–1466. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Choi DC, Lee JY, Lim EJ, Baik HH, Oh TH
and Yune TY: Inhibition of ROS-induced p38MAPK and ERK activation
in microglia by acupuncture relieves neuropathic pain after spinal
cord injury in rats. Exp Neurol. 236:268–282. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xie D, Wu X, Lan L, Shangguan F, Lin X,
Chen F, Xu S, Zhang Y, Chen Z, Huang K, et al: Downregulation of
TFAM inhibits the tumorigenesis of non-small cell lung cancer by
activating ROS-mediated JNK/p38MAPK signaling and reducing cellular
bioenergetics. Oncotarget. 7:11609–11624. 2016. View Article : Google Scholar : PubMed/NCBI
|
